Thomas Hesterkamp
Impact in
-
- Toxin Mechanisms and Immunotoxins
-
- Heat shock proteins research
- RNA and protein synthesis mechanisms
- Signaling Pathways in Disease
- Protein Structure and Dynamics
Papers in
-
- Toxin Mechanisms and Immunotoxins 3
- Immunotherapy and Immune Responses 2
-
- Heat shock proteins research 2
- vaccines and immunoinformatics approaches 1
- Co-authors
- Bernd Bukau (3 shared papers)Stephen C. Hauser (1 shared paper)Joen Luirink (1 shared paper)Christine Dahlke (1 shared paper)Anahita Fathi (1 shared paper)Svenja Hardtke (1 shared paper)Manfred Schuster (1 shared paper)Asisa Volz (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (1 paper)Proceedings of the National Academy of Sciences (1 paper)Trends in Cell Biology (1 paper)npj Vaccines (1 paper)FEBS Letters (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
Thomas Hesterkamp
5 papers receiving 293 citations
Peers
Comparison fields: 5 of 49
- Immunology 127
- Molecular Biology 269
- Endocrinology 9
- Genetics 47
- Cell Biology 25
Countries citing papers authored by Thomas Hesterkamp
This map shows the geographic impact of Thomas Hesterkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hesterkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hesterkamp more than expected).
Fields of papers citing papers by Thomas Hesterkamp
This network shows the impact of papers produced by Thomas Hesterkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hesterkamp. The network helps show where Thomas Hesterkamp may publish in the future.
Co-authors
The 20 scholars most cited alongside Thomas Hesterkamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 197 | |
| 2 | 1996 | 55 | |
| 3 | 1996 | 45 | |
| 4 | 2024 | 3 | |
| 5 | 2013 | 1 |
About Thomas Hesterkamp
Thomas Hesterkamp is a scholar working on Immunology, Molecular Biology, Infectious Diseases, Ecology and Oncology, having authored 5 papers that have together received 301 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (3 papers), Heat shock proteins research (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Bacterial Genetics and Biotechnology (1 paper), Bacteriophages and microbial interactions (1 paper), vaccines and immunoinformatics approaches (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Immunology (127 citations), Molecular Biology (269 citations), Endocrinology (9 citations), Genetics (47 citations) and Cell Biology (25 citations). Thomas Hesterkamp has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Bernd Bukau, Stephen C. Hauser, Joen Luirink, Christine Dahlke, Anahita Fathi, Svenja Hardtke, Manfred Schuster, Asisa Volz, Hans Loibner and Sibylle C. Mellinghoff. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Proceedings of the National Academy of Sciences, Trends in Cell Biology, npj Vaccines and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.